Mutations in these two regions not only reduce apoptosis but also promote tumor infiltration and increase the activity of the downstream kinase PI3K, contributing to the activation of the PI3K/AKT signaling pathway.46, 47. The gene discussed is PIK3CA; the disease is neoplasm.